Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Pancreatic Neoplasms HELP
Based on 31,636 articles published since 2008
|||| 49 

These are the 31636 published articles about Pancreatic Neoplasms that originated from Worldwide during 2008-2019.
 
+ Citations + Abstracts
Pages: 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · 11 · 12 · 13 · 14 · 15 · 16 · 17 · 18 · 19 · 20
151 Editorial Radiofrequency ablation for intraductal extension of ampullary neoplasms: Are we ready to feel the burn? 2017

Watson, Rabindra R / Muthusamy, V Raman. ·Vatche and Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine at UCLA, Los Angeles, California, USA. ·Gastrointest Endosc · Pubmed #28610856.

ABSTRACT: -- No abstract --

152 Editorial Pancreatic Cysts: Controversies, Advances, Diagnoses, and Therapies. 2017

Barkin, Jodie A / Barkin, Jamie S. ·From the Division of Gastroenterology, Department of Medicine, University of Miami Leonard M. Miller School of Medicine, Miami, FL. ·Pancreas · Pubmed #28609359.

ABSTRACT: Pancreatic cysts are commonly found on cross-sectional imaging. The question arises in determining which lesions are premalignant or malignant and may require further testing, intervention, or follow-up. In pancreatic cysts without obvious malignancy on imaging, we approach them using the Four "S" Criteria. These are (1) symptoms that may be originating from the pancreatic cyst; (2) size of the cyst 2 cm or larger and/or main pancreatic duct greater than 5 mm; (3) survival of the patient, based on comorbidity index to determine surgical fitness; and then endoscopic ultrasound with fine needle aspiration (FNA) recommended to determine (4) solid component presence in the cyst, namely, nodule or thick walls, as well as to perform FNA to obtain cyst content. Current cyst fluid analysis options include use of cytology to determine presence of malignancy and carcinoembryonic antigen and fluid genetics to identify potentially premalignant lesions. The aims of this article are to explore current management guidelines for pancreatic cysts, present a comprehensive approach to pancreatic cysts, and explain the advantages and disadvantages of each option for evaluation of pancreatic cysts including endoscopic ultrasound with FNA with cyst fluid analysis using an evidence-based approach.

153 Editorial Accelerating progress in the fight against pancreatic cancer Proceedings of the 2017 Leo and Anne Albert Symposium for Pancreatic Cancer Research. 2017

Melstrom, Laleh G / Singh, Gagandeep / Fong, Yuman. ·Assistant Professor of Surgery and Experimental Therapeutics, City of Hope Medical Center. · Clinical Professor of Surgery, City of Hope Medical Center. · Professor and Sangiacomo Chair and Chairman Department of Surgery, City of Hope Medical Center. ·J Surg Oncol · Pubmed #28608945.

ABSTRACT: -- No abstract --

154 Editorial Sno(RNA)wing and Pancreatic Cancer Metastasis. 2017

Ramakrishnan, Sundaram. ·Department of Surgery, Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, Florida. Electronic address: sramakrishnan@miami.edu. ·Gastroenterology · Pubmed #28572011.

ABSTRACT: -- No abstract --

155 Editorial Have the current and promising therapeutic options changed the surgeon's role in the treatment of pancreatic cancer? 2017

Vicente, Emilio / Quijano, Yolanda. ·- Madrid Sanchinarro University Hospital, "Clara Campal" Oncology Center, Madrid, Spain. ·Rev Col Bras Cir · Pubmed #28489204.

ABSTRACT: -- No abstract --

156 Editorial Resectable pancreatic adenocarcinomas: will neoadjuvant FOLFIRINOX replace upfront surgery in the standard of care? 2017

Antonios, Amine / Gharios, Joseph / Tohme, Cyril. ·Surgery Department, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon. ·Future Oncol · Pubmed #28481149.

ABSTRACT: -- No abstract --

157 Editorial Comment re: "Optimize CA19-9 in detecting pancreatic cancer by Lewis and Secretor genotyping". 2017

Wannhoff, A / Weiss, K H / Hackert, T / Gotthardt, D N. ·Department of Internal Medicine IV, University Hospital Heidelberg, Heidelberg, Germany. · Department of General, Visceral and Transplant Surgery, University Hospital Heidelberg, Heidelberg, Germany. · Department of Internal Medicine IV, University Hospital Heidelberg, Heidelberg, Germany. Electronic address: daniel.gotthardt@gotthardt.com. ·Pancreatology · Pubmed #28434838.

ABSTRACT: -- No abstract --

158 Editorial Pancreatic cyst guidelines: Which one to live by? 2017

Basar, Omer / Brugge, William R. ·Pancreas Biliary Center, Gastrointestinal Unit, Massachusetts General Hospital, Boston, Massachusetts, USA. ·Gastrointest Endosc · Pubmed #28411756.

ABSTRACT: -- No abstract --

159 Editorial Pancreatic cancer: how can we tackle the lack of progress? 2017

The Lancet Gastroenterology Hepatology, ?. · ·Lancet Gastroenterol Hepatol · Pubmed #28403985.

ABSTRACT: -- No abstract --

160 Editorial Editorial - Special issue on Fighting Pancreatic Cancer. 2017

Li, Min. ·The University of Oklahoma Health Sciences Center, Department of Medicine, 975 NE 10th Street, BRC 1262A, Oklahoma City, OK 73104, United States. Electronic address: Min-Li@ouhsc.edu. ·Cancer Lett · Pubmed #28400337.

ABSTRACT: -- No abstract --

161 Editorial Can protein science solve the unmet needs in pancreatic cancer diagnosis and therapy? 2017

Ansari, Daniel / Sambergs, Fredrik / Johansson, Love / Andersson, Roland. ·a Department of Surgery, Clinical Sciences Lund , Lund University, Skåne University Hospital , Lund , Sweden. ·Expert Rev Proteomics · Pubmed #28388239.

ABSTRACT: -- No abstract --

162 Editorial MYCN-mediated murine cancer models. 2017

Althoff, Kristina / Schramm, Alexander. ·Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. ·Aging (Albany NY) · Pubmed #28377536.

ABSTRACT: -- No abstract --

163 Editorial Pancreatic Cancer: Challenge and Inspiration. 2017

Bates, Susan E. ·Columbia University Medical Center. ·Clin Cancer Res · Pubmed #28373360.

ABSTRACT: -- No abstract --

164 Editorial The role of γδ T cells in pancreatic cancer: what could this mean for the clinic? 2017

Daley, Donnele / Miller, George. ·a S. Arthur Localio Laboratory, Department of Surgery , New York University School of Medicine , New York , NY , USA. · b S. Arthur Localio Laboratory, Department of Cell Biology , New York University School of Medicine , New York , NY , USA. ·Expert Rev Gastroenterol Hepatol · Pubmed #28345379.

ABSTRACT: -- No abstract --

165 Editorial The Countdown to a Paradigm Shift in Diagnosing Pancreatic Ductal Adenocarcinoma. 2017

Coté, Gregory A. ·Division of Gastroenterology and Hepatology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina. ·Clin Gastroenterol Hepatol · Pubmed #28300695.

ABSTRACT: -- No abstract --

166 Editorial Pancreatic ductal adenocarcinoma: is a cure possible? 2017

Ansari, Daniel / Andersson, Roland. ·Department of Surgery, Clinical Sciences Lund, Lund University, Skåne University Hospital, Lund, Sweden. ·Future Oncol · Pubmed #28266248.

ABSTRACT: -- No abstract --

167 Editorial Private Funding for Pancreatic Cancer Research: More Than a Chip Shot. 2017

Hendifar, Andrew E / Davies, Lynne / Tuli, Richard. ·Cedars-Sinai Medical Center, Los Angeles, California. · International Cancer Research Partnership, London, United Kingdom. ·Gastroenterology · Pubmed #28259790.

ABSTRACT: -- No abstract --

168 Editorial Pancreaticoduodenectomy for pancreatic cancer: perspective from the United States. 2017

Ejaz, Aslam / He, Jin. ·Department of Surgery, the Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. · Department of Surgery, the Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. jhe11@jhmi.edu. ·Chin Clin Oncol · Pubmed #28249540.

ABSTRACT: -- No abstract --

169 Editorial Presence of small pancreatic cystic lesions should not preclude liver transplantation. 2017

Barkin, Jodie A / Barkin, Jamie S. ·Division of Gastroenterology, Department of Medicine, Leonard M. Miller School of Medicine, University of Miami, Miami, FL. ·Liver Transpl · Pubmed #28103652.

ABSTRACT: -- No abstract --

170 Editorial CXCR2 inhibition in pancreatic cancer: opportunities for immunotherapy? 2017

Morton, Jennifer P / Sansom, Owen J. ·Cancer Research UK Beatson Institute, Switchback Rd, Glasgow, G61 1BD, UK. · Institute of Cancer Sciences, University of Glasgow, University Avenue, Glasgow, G12 8QQ, UK. ·Immunotherapy · Pubmed #28000523.

ABSTRACT: -- No abstract --

171 Editorial What's in a Name? Steady Progress in Staging Pancreatic Neuroendocrine Tumors. 2017

Halperin, Daniel M / Yao, James C / Dasari, Arvind. ·Daniel M. Halperin, James C. Yao, and Arvind Dasari, MD Anderson Cancer Center, Houston, TX. ·J Clin Oncol · Pubmed #27893328.

ABSTRACT: -- No abstract --

172 Editorial Epigenomic therapies: the potential of targeting SIRT6 for the treatment of pancreatic cancer. 2017

Demir, Ihsan Ekin / Ceyhan, Güralp O / Friess, Helmut. ·a Department of Surgery, Klinikum rechts der Isar , Technische Universität München , Munich , Germany. ·Expert Opin Ther Targets · Pubmed #27885875.

ABSTRACT: -- No abstract --

173 Editorial Will gemcitabine monotherapy be dethroned as the adjuvant chemotherapy in pancreatic adenocarcinoma? 2017

Kourie, Hampig Raphael / Gharios, Joseph / Kattan, Joseph. ·Oncology Department, Jules Bordet Institute, Brussels, Belgium. · Oncology Department, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon. · General Surgery Department, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon. ·Future Oncol · Pubmed #27624286.

ABSTRACT: -- No abstract --

174 Editorial Percutaneous ablation of pancreatic cancer. 2016

D'Onofrio, Mirko / Ciaravino, Valentina / De Robertis, Riccardo / Barbi, Emilio / Salvia, Roberto / Girelli, Roberto / Paiella, Salvatore / Gasparini, Camilla / Cardobi, Nicolò / Bassi, Claudio. ·Mirko D'Onofrio, Valentina Ciaravino, Riccardo De Robertis, Camilla Gasparini, Nicolò Cardobi, Department of Radiology, G.B. Rossi Hospital, University of Verona, 37134 Verona, Italy. ·World J Gastroenterol · Pubmed #27956791.

ABSTRACT: Pancreatic ductal adenocarcinoma is a highly aggressive tumor with an overall 5-year survival rate of less than 5%. Prognosis and treatment depend on whether the tumor is resectable or not, which mostly depends on how quickly the diagnosis is made. Chemotherapy and radiotherapy can be both used in cases of non-resectable pancreatic cancer. In cases of pancreatic neoplasm that is locally advanced, non-resectable, but non-metastatic, it is possible to apply percutaneous treatments that are able to induce tumor cytoreduction. The aim of this article will be to describe the multiple currently available treatment techniques (radiofrequency ablation, microwave ablation, cryoablation, and irreversible electroporation), their results, and their possible complications, with the aid of a literature review.

175 Editorial Special issue editorial-Cancer Genetics. 2016

Rosemurgy, Alexander. · ·Cancer Genet · Pubmed #27931696.

ABSTRACT: -- No abstract --

Back · Next